The NIH’s funding opportunity (RFA-DA-25-070) supports the development and testing of integrated models of care that combine HIV/AIDS, addiction treatment, and primary care services. This initiative, offered under the R34 grant mechanism, allows for clinical trials but does not require them, making it flexible for exploratory and developmental studies that could lead to more comprehensive clinical trials in the future.

Eligible applicants span a range of organizations, including state and local governments, higher education institutions, nonprofits, for-profit entities, and minority-serving institutions like HBCUs and Hispanic-serving Institutions. Foreign entities may not apply directly but can participate as part of U.S.-based applications.

With an award ceiling of $450,000 and no cost-sharing requirement, this grant aims to enhance healthcare delivery for populations impacted by both HIV and substance use disorders. Applications are due by March 19, 2025, with further details available on the NIH website. Interested applicants are encouraged to reach out to NIH Grants Information for guidance.